{"name":"Mohsen Pourazizi","slug":"mohsen-pourazizi","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE5fSFNNQTJseVpTZ09VNnYtNGY4OUhfOEF6SF9NRmw5NTJZVDBmTlZ0ejdvd0VZem5WZklPZTFjeEFFSVI0OFo3SVpUT1VNWTBVTUZHaEdkMFRPMl9FNnRmTUpmdWRNbVBHTFE?oc=5","date":"2023-06-13","type":"pipeline","source":"Wiley Online Library","summary":"Recurring nodular scleritis following inactivated vaccination for COVID‐19 - Peyman - 2023 - Clinical Case Reports - Wiley Online Library","headline":"Recurring nodular scleritis following inactivated vaccination for COVID‐19 - Peyman - 2023 - Clinical Case Reports","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTE5YM3M3emZVMnZIRDJOR2RacjJVUEp0WUNsSFNMR0FkWmlWUDJGWW1CNjYtUmp5TDRyQU1qRlUtZ1daM0g2VkZRc1g1TDVnVi1VM2cwUnVzTFhGcFJfTTBzbko1ZVl0UQ?oc=5","date":"2015-07-27","type":"pipeline","source":"Wiley Online Library","summary":"Complementary Therapies for Idiopathic Hirsutism: Topical Licorice as Promising Option - Wiley Online Library","headline":"Complementary Therapies for Idiopathic Hirsutism: Topical Licorice as Promising Option","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}